Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2
Authors:
- 1 August 2005
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 73 (2) , 103-111
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 33 references indexed in Scilit:
- Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancerGynecologic Oncology, 2004
- Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell LineCancer Research, 2004
- Cyclooxygenase-1 and 2 in normal and malignant human ovarian epitheliumGynecologic Oncology, 2004
- Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor ReceptorJournal of Biological Chemistry, 2003
- The effect of cyclooxygenase‐2 expression on tumor vascularity in advanced stage ovarian serous carcinomaCancer, 2003
- Prostaglandin E synthaseProstaglandins & Other Lipid Mediators, 2002
- Identification and Characterization of a Novel Type of Membrane-Associated Prostaglandin E SynthaseBiochemical and Biophysical Research Communications, 2002
- Expression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian CarcinomaThe American Journal of Pathology, 2002
- PGE2 Stimulates VEGF Expression in Endothelial Cells via ERK2/JNK1 Signaling PathwaysBiochemical and Biophysical Research Communications, 2001
- Establishment and Characterization of Two Human Ovarian Clear Cell Adenocarcinoma Lines from Metastatic Lesions with Different PropertiesGynecologic Oncology, 1995